Start Date
February 29, 2012
Primary Completion Date
June 30, 2014
Study Completion Date
June 30, 2018
Cs-131 brachytherapy seeds
Cesium-131 is another radiation seed that may more effectively treat lung cancer patients. Cs-131 has been previously used in prostate cancer successfully. Cs-131 has similar energy to I-125 but has a much shorter half life (9days as compared to 60 days for I-125). Patients who receive Cs-131 radiation seeds are expected to be radioactive for 30 days (1 month) as compared to 180 days (6 months) with I-125.
Weill Cornell Medical College, New York
Collaborators (1)
IsoRay Medical, Inc.
INDUSTRY
Weill Medical College of Cornell University
OTHER